Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

SPECTRUM PHARMACEUTICALS, INC.

(SPPI)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about SPECTRUM PHARMACEUTICALS, INC.
12/06SPECTRUM PHARMACEUTICALS : Current Corporate Presentation
PU
12/06Spectrum Pharmaceuticals Submits New Drug Application for Poziotinib to US Food and Dru..
MT
12/06Spectrum Pharmaceuticals Submits New Drug Application for Poziotinib
BU
12/01Spectrum Pharmaceuticals CEO Agrees to Retire, COO Named Successor From Dec. 31
MT
12/01Spectrum Pharmaceuticals Announces Changes to Management Team and Board of Directors
BU
12/01Spectrum Pharmaceuticals, Inc. Announces Appointment of Tom Riga as President and CEO, ..
CI
12/01Spectrum Pharmaceuticals, Inc. Announces Changes to Board of Directors
CI
11/30Spectrum Pharmaceuticals to Participate in JMP Securities Hematology and Oncology Summi..
BU
11/11Spectrum Pharmaceuticals to Participate in 2021 Jefferies London Healthcare Conference
BU
11/10Spectrum Pharmaceuticals Reports Third Quarter 2021 Financial Results and Corporate Upd..
PU
11/10Spectrum Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine ..
CI
11/10SPECTRUM PHARMA : Q3 Earnings Snapshot
AQ
11/10Spectrum Pharmaceuticals Reports Third Quarter 2021 Financial Results and Corporate Upd..
BU
11/03Spectrum Pharmaceuticals to Report Third Quarter 2021 Financial Results and Provide Cor..
BU
11/03SHAREHOLDER ALERT : Robbins LLP Investigates Spectrum Pharmaceuticals, Inc. (SPPI) for Mis..
BU
10/07SPECTRUM PHARMACEUTICALS : Pharma's Poziotinib Combo Shows 'Promising' Data in Preclinical..
MT
10/07AACR-NTI-EROTC VIRTUAL INTERNATIONAL : Pan-ErbB inhibition enhances activity of KRASG12C i..
PU
10/07SPECTRUM PHARMACEUTICALS : Announces Presentation of Poziotinib in Combination with KRASG1..
BU
10/07Spectrum Pharmaceuticals Announces Presentation of Poziotinib in Combination with KRASG..
CI
10/04SHAREHOLDER ALERT : Robbins LLP Reminds Investors that Spectrum Pharmaceuticals, Inc. (SPP..
BU
09/22SPECTRUM PHARMACEUTICALS : to Participate in 2021 Cantor Virtual Global Healthcare Confere..
BU
09/18ESMO CONGRESS 2021 : Efficacy and Safety of Poziotinib in Treatment-naïve NSCLC Harboring ..
PU
09/18SPECTRUM PHARMACEUTICALS : Presents Late Breaker Oral Presentation of Poziotinib Data in F..
BU
09/18Spectrum Pharmaceuticals, Inc. Presents Late Breaker Oral Presentation of Poziotinib Da..
CI
09/13SPECTRUM PHARMACEUTICALS : Announces Late-Breaking Oral Presentation of Data for Poziotini..
BU
09/09SPECTRUM PHARMACEUTICALS : Current Corporate Presentation
PU
09/07SHAREHOLDER ALERT : Robbins LLP Announces that Spectrum Pharmaceuticals, Inc. (SPPI) is Be..
BU
09/02GLANCY PRONGAY & MURRAY LLP : a Leading Securities Fraud Law Firm, Announces Investigation..
BU
09/02THE LAW OFFICES OF FRANK R. CRUZ : Announces Investigation of Spectrum Pharmaceuticals, In..
BU
09/02INVESTOR ALERT : Law Offices of Howard G. Smith Announces Investigation of Spectrum Pharma..
BU
08/18SPECTRUM PHARMACEUTICALS : B. Riley Lowers Spectrum Pharmaceuticals' PT to $6 from $8 on '..
MT
08/12SPECTRUM PHARMA : Q2 Earnings Snapshot
AQ
08/12SPECTRUM PHARMACEUTICALS : The company is requesting a meeting with the FDA to clarify the..
PU
08/12SPECTRUM PHARMACEUTICALS : Reports Second Quarter 2021 Financial Results and Corporate Upd..
BU
08/12Spectrum Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter Ended Ju..
CI
08/10SPECTRUM ALERT : Bragar Eagel & Squire, P.C. is Investigating Spectrum Pharmaceuticals, In..
BU
08/09SHAREHOLDER ALERT : Pomerantz Law Firm Investigates Claims On Behalf of Investors of Spect..
PR
08/06Top Midday Decliners
MT
08/06(SPPI) ALERT : Did You Lose Money on Your Investment? Contact Johnson Fistel Regarding Inv..
PR
08/06Spectrum Pharmaceuticals Says FDA Rejects Application for Neutropenia Drug Candidate; S..
MT
08/06Wall Street Sees Narrowly Mixed Open, Strong Jobs Data in Focus
MT
08/06Spectrum Pharma Shares Tumble as FDA Turns Away Rolontis Application
DJ
08/06Top Premarket Decliners
MT
08/06SPECTRUM PHARMACEUTICALS : Receives Complete Response Letter from FDA for ROLONTIS® (eflap..
BU
08/06Spectrum Pharmaceuticals Receives Complete Response Letter from FDA for ROLONTIS® (efla..
CI
08/06FDA Rejects Spectrum's Rolontis Due to Manufacturing Issues
DJ
08/05SPECTRUM PHARMACEUTICALS : to Report Second Quarter 2021 Financial Results and Provide Cor..
BU
07/14SPECTRUM PHARMACEUTICALS : Files for Up to $300 Million Mixed-Securities Shelf
MT
06/25SPECTRUM PHARMACEUTICALS, INC.(NASDA : SPPI) dropped from Russell Small Cap Comp Value Ind..
CI
06/25SPECTRUM PHARMACEUTICALS, INC.(NASDA : SPPI) dropped from Russell 3000 Value Index
CI
06/25SPECTRUM PHARMACEUTICALS, INC.(NASDA : SPPI) added to Russell 3000E Growth Index
CI
06/25SPECTRUM PHARMACEUTICALS, INC.(NASDA : SPPI) dropped from Russell Microcap Value Index
CI
06/25SPECTRUM PHARMACEUTICALS, INC.(NASDA : SPPI) added to Russell 3000 Growth Index
CI
06/25SPECTRUM PHARMACEUTICALS, INC.(NASDA : SPPI) added to Russell 2500 Growth Index
CI
06/25SPECTRUM PHARMACEUTICALS, INC.(NASDA : SPPI) added to Russell Microcap Growth Index
CI
06/25SPECTRUM PHARMACEUTICALS, INC.(NASDA : SPPI) dropped from Russell 3000E Value Index
CI
06/25SPECTRUM PHARMACEUTICALS, INC.(NASDA : SPPI) added to Russell Small Cap Comp Growth Index
CI
06/25SPECTRUM PHARMACEUTICALS, INC.(NASDA : SPPI) dropped from Russell 2500 Value Index
CI
06/25SPECTRUM PHARMACEUTICALS, INC.(NASDA : SPPI) added to Russell 2000 Growth Index
CI
06/25SPECTRUM PHARMACEUTICALS, INC.(NASDA : SPPI) dropped from Russell 2000 Value Index
CI
06/04SPECTRUM PHARMACEUTICALS : Reports Data From First 3 Cohorts of Poziotinib Lung Cancer Tri..
MT
06/042021 ASCO ANNUAL MEETING : CNS activity of poziotinib in NSCLC with exon 20 insertion muta..
PU
06/04SPECTRUM PHARMACEUTICALS : Presents Poziotinib Data in Patients with Brain Metastases from..
BU
06/04Spectrum Pharmaceuticals Presents Poziotinib Data in Patients with Brain Metastases fro..
CI
06/02SPECTRUM PHARMACEUTICALS : Letter from Deloitte & Touche LLP addressed to the Securities E..
PU
06/01SPECTRUM PHARMACEUTICALS : FDA Initiates Inspection of Spectrum Pharmaceuticals' Rolontis ..
MT
06/01SPECTRUM PHARMACEUTICALS : Announces That the ROLONTIS® (eflapegrastim) Pre-Approval Inspe..
BU
06/01Spectrum Pharmaceuticals Announces Initiation of Pre-Approval Inspection for ROLONTIS®
CI
05/28SPECTRUM PHARMACEUTICALS : to Present Data for Poziotinib in Patients with Brain Metastase..
BU
05/27SPECTRUM PHARMACEUTICALS : to Participate in Two Upcoming Investor Conferences in June
BU
05/13Spectrum Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended Mar..
CI
05/13SPECTRUM PHARMA : Q1 Earnings Snapshot
AQ
05/13SPECTRUM PHARMACEUTICALS : Q1 Adjusted Loss Narrows
MT
05/13SPECTRUM PHARMACEUTICALS : Reports First Quarter 2021 Financial Results and Corporate Upda..
BU
05/12NEUTROPENIA PIPELINE : Emerging Therapies and Key pharma players involved by DelveInsight ..
AQ
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on SPECTRUM PHARMACEUTICALS, INC.
12/07/21